Stéphane Breault
University Hospital of Lausanne
7 Papers
25 Citations
Stéphane Breault is an academic researcher from University Hospital of Lausanne. The author has contributed to research in topics: Catheter & Hazard ratio. The author has an hindex of 6, co-authored 7 publications. Previous affiliations of Stéphane Breault include University of Lausanne.
Chat about Author
Papers
Association between computed tomography obstruction index and mortality in elderly patients with acute pulmonary embolism: A prospective validation study.
Marie Méan,Tobias Tritschler,Andreas Limacher,Stéphane Breault,Nicolas Rodondi,Drahomir Aujesky,Salah D. Qanadli +6 more
TL;DR: In elderly patients with acute PE, the CTOI was associated with PE-related 90-day mortality but not with overall 90- day mortality, and both measures predicted VTE recurrence and LOS.
21
Endovascular treatment of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia.
Malik Babaker,Stéphane Breault,Catherine Beigelman,Romain Lazor,Nicole Aebischer,Salah D. Qanadli +5 more
TL;DR: This study shows a minimal complication rate and little recurrence in vaso-occlusion of pulmonary arteriovenous malformations in Rendu-Osler-Weber disease, whether by coils, plugs, or combined treatments.
11
Prevalence of Acute Coronary Syndrome in Patients Suspected for Pulmonary Embolism or Acute Aortic Syndrome: Rationale for the Triple Rule-Out Concept
TL;DR: The prevalence of ACS and AAS among patients suspected clinically of having PE is limited while the prevalence ofACS and PE among patients believed to be having AAS is significant, and patients suspected for PE could be evaluated with dedicated PE CTA while those suspected for AAS should still be triaged using TRO protocol.
Percutaneous endovascular salvage techniques for implanted venous access device dysfunction.
TL;DR: These IVAD salvage techniques are safe and efficient and in patients who still require long-term use of their IVAD, these procedures can be performed safely to avoid catheter replacement.
Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes : long-term follow-up.
TL;DR: Percutaneous endovascular techniques to treat benign SVC syndrome are safe with good long term patency and recurrence of symptoms can easily be addressed by repeat procedure.